Tonix Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TNXP and other ETFs, options, and stocks.

About TNXP

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. 

CEO
Seth Lederman
CEOSeth Lederman
Employees
142
Employees142
Headquarters
Berkeley Heights, New Jersey
HeadquartersBerkeley Heights, New Jersey
Founded
2007
Founded2007
Employees
142
Employees142

TNXP Key Statistics

Market cap
186.40M
Market cap186.40M
Price-Earnings ratio
-0.97
Price-Earnings ratio-0.97
Dividend yield
Dividend yield
Average volume
557.66K
Average volume557.66K
High today
$14.00
High today$14.00
Low today
$13.10
Low today$13.10
Open price
$13.16
Open price$13.16
Volume
313.76K
Volume313.76K
52 Week high
$69.97
52 Week high$69.97
52 Week low
$11.60
52 Week low$11.60

Stock Snapshot

As of today, Tonix Pharmaceuticals(TNXP) shares are valued at $13.65. The company's market cap stands at 186.4M, with a P/E ratio of -0.97.

As of 2026-04-03, Tonix Pharmaceuticals(TNXP) stock has fluctuated between $13.10 and $14.00. The current price stands at $13.65, placing the stock +4.2% above today's low and -2.5% off the high.

The Tonix Pharmaceuticals(TNXP)'s current trading volume is 313.76K, compared to an average daily volume of 557.66K.

In the last year, Tonix Pharmaceuticals(TNXP) shares hit a 52-week high of $69.97 and a 52-week low of $11.60.

In the last year, Tonix Pharmaceuticals(TNXP) shares hit a 52-week high of $69.97 and a 52-week low of $11.60.

TNXP News

TipRanks 1d
Tonix Pharma CEO Makes Bold Insider Move Amid Market Uncertainty

New insider activity at Tonix Pharma ( (TNXP) ) has taken place on April 1, 2026. Unlock hedge fund-level data and powerful investing tools for smarter, sharpe...

TipRanks 3d
Tonix Pharma Advances TNX-4800 Lyme Disease Prevention Program

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

TipRanks 3d
Tonix Pharmaceuticals presents TNX-4800 data, to initiate adaptive field study

Tonix Pharmaceuticals (TNXP) announced Phase 1 data of TNX-4800 was presented at the World Vaccine Congress Washington 2026. Tonix also announced its planned st...

More TNXP News

Benzinga 4d
Tonix Pharmaceuticals Stock Hits New 52-Week Low: What's Driving The Action?

Tonix Pharmaceuticals shares are approaching critical lows. Why did TNXP hit a new low? Reverse Split Proposal Adds New Pressure On Tonix Shares The filing also...

Tonix Pharmaceuticals Stock Hits New 52-Week Low: What's Driving The Action?

People also own

Based on the portfolios of people who own TNXP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.